ClinicalTrials.Veeva

Menu

The Influence of Sensory Phenotype on the Risk of Developing Neuropathic Pain

U

University of Kiel

Status

Unknown

Conditions

Polyneuropathy
Neuropathic Pain
Peripheral Nerve Injury

Treatments

Other: QST, Questionnaires

Study type

Observational

Funder types

Other

Identifiers

NCT02666456
DOLORisk WP4

Details and patient eligibility

About

Cross-sectional and longitudinal analysis of the somatosensory phenotype, assessed by quantitative sensory testing (QST) and Information obtained by questionnaires to detect risk factors for neuropathic pain development and chronification in painless and chronic pain patients.

Enrollment

1,500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Chronic peripheral neuropathic pain or
  • Painless Patient with risk to develop neuropathic pain (post-surgery, chemotherapy-induced)

Exclusion criteria

  • Minors

Trial design

1,500 participants in 2 patient groups

Cross-sectional cohort
Description:
Patients with chronic peripheral neuropathic pain
Treatment:
Other: QST, Questionnaires
Longitudinal cohort
Description:
Painless patients before and after potential chronic neuropathic pain-inducing interventions (chemotherapy, Operation)
Treatment:
Other: QST, Questionnaires

Trial contacts and locations

0

Loading...

Central trial contact

Andreas Binder, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems